Cancer News

As the American Society of Clinical Oncology (ASCO) Annual Meeting unfolds, researchers from Roswell Park Comprehensive Cancer Center are making significant strides in the fields of breast cancer...

Pancreatic cancer has long been a formidable adversary in oncology, notorious for its late-stage diagnosis and grim survival statistics. However, recent research presented at the American Society of...

A recent study has unveiled a groundbreaking medication that could significantly enhance the survival rate for patients battling advanced pancreatic cancer. Presented at the American Society of...

An international study led by researchers at UCLA has unveiled exciting results for patients battling metastatic pancreatic cancer. The investigational targeted therapy, daraxonrasib, has...

Recent advancements in cancer treatment have brought renewed hope for patients battling metastatic pancreatic cancer, a notoriously aggressive form of the disease. An international study co-led by...

Recent findings from the Phase 3 BREAKWATER trial presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting have brought new hope for patients suffering from metastatic...

In a significant advancement for the treatment of advanced colorectal cancer, researchers from The University of Texas MD Anderson Cancer Center have unveiled promising results from the BREAKWATER...

Recent findings from a significant clinical trial have brought new hope for patients suffering from a rare genetic subtype of lung cancer, known as RET fusion-positive non-small cell lung cancer...

Recent advancements in cancer treatment have taken a significant leap forward, particularly for patients suffering from a rare genetic subtype of lung cancer. A new study co-led by researchers at the...

Recent findings have illuminated the complexities of treating pancreatic cancer, particularly highlighting the mechanisms behind resistance to KRAS inhibitors. This research, which explores the...

Recent research has highlighted a significant challenge in treating pancreatic cancer—resistance to KRAS inhibitors. A study published by researchers reveals that the protein PI3K can activate...

In an era where patients increasingly turn to the internet for health information, recent research highlights significant shortcomings in the quality and clarity of online resources regarding...

In an era where the integration of artificial intelligence (AI) is increasingly influencing cancer research and treatment, a recent study highlights significant deficiencies in the quality and...

Recent findings from a phase 3 clinical trial have revealed promising results for high-risk localized or locally advanced prostate cancer patients treated with apalutamide in conjunction with...

Recent findings presented at the American Society for Clinical Oncology (ASCO) Annual Meeting have unveiled significant advancements in the treatment of high-risk localized or locally advanced...

Recent findings from the RASolute 302 trial have brought a wave of optimism in the treatment of metastatic pancreatic cancer, a notoriously aggressive disease. This pivotal study has shown that...

Recent findings from the pivotal RASolute 302 trial have introduced a new treatment option that could significantly improve outcomes for patients suffering from metastatic pancreatic cancer. The...

Recent findings from a multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center have unveiled a groundbreaking approach to treating brain metastases. This...

Recent advancements in oncology have unveiled a groundbreaking approach to treating brain metastases, a challenging complication for many cancer patients. A multicenter clinical trial has...

Recent findings from a multicenter clinical trial have illuminated a groundbreaking approach to treating brain metastases, significantly enhancing patient outcomes. This innovative method, known as...